These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35970679)

  • 21. Patient-reported outcomes in clinical trials of CKD-related therapies: report of a symposium sponsored by the national kidney foundation and the U.S. Food and Drug Administration.
    Perrone RD; Coons SJ; Cavanaugh K; Finkelstein F; Meyer KB
    Am J Kidney Dis; 2013 Dec; 62(6):1046-57. PubMed ID: 23988757
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation.
    Greene T; Ying J; Vonesh EF; Tighiouart H; Levey AS; Coresh J; Herrick JS; Imai E; Jafar TH; Maes BD; Perrone RD; Del Vecchio L; Wetzels JFM; Heerspink HJL; Inker LA
    J Am Soc Nephrol; 2019 Sep; 30(9):1756-1769. PubMed ID: 31292198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.
    Ji E; Kim YS
    Korean J Intern Med; 2016 Nov; 31(6):1120-1130. PubMed ID: 27017386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Receipt of Nephrology Care and Clinical Outcomes Among Veterans With Advanced CKD.
    Fung E; Chang TI; Chertow GM; Thomas IC; Asch SM; Kurella Tamura M
    Am J Kidney Dis; 2017 Nov; 70(5):705-714. PubMed ID: 28811048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies.
    Coresh J; Heerspink HJL; Sang Y; Matsushita K; Arnlov J; Astor BC; Black C; Brunskill NJ; Carrero JJ; Feldman HI; Fox CS; Inker LA; Ishani A; Ito S; Jassal S; Konta T; Polkinghorne K; Romundstad S; Solbu MD; Stempniewicz N; Stengel B; Tonelli M; Umesawa M; Waikar SS; Wen CP; Wetzels JFM; Woodward M; Grams ME; Kovesdy CP; Levey AS; Gansevoort RT;
    Lancet Diabetes Endocrinol; 2019 Feb; 7(2):115-127. PubMed ID: 30635225
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low renal replacement therapy incidence among slowly progressing elderly chronic kidney disease patients referred to nephrology care: an observational study.
    Lundström UH; Gasparini A; Bellocco R; Qureshi AR; Carrero JJ; Evans M
    BMC Nephrol; 2017 Feb; 18(1):59. PubMed ID: 28187786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A predictive model for progression of chronic kidney disease to kidney failure.
    Tangri N; Stevens LA; Griffith J; Tighiouart H; Djurdjev O; Naimark D; Levin A; Levey AS
    JAMA; 2011 Apr; 305(15):1553-9. PubMed ID: 21482743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials.
    Lambers Heerspink HJ; Tighiouart H; Sang Y; Ballew S; Mondal H; Matsushita K; Coresh J; Levey AS; Inker LA
    Am J Kidney Dis; 2014 Dec; 64(6):860-6. PubMed ID: 25441439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GFR slope as a surrogate endpoint for CKD progression in clinical trials.
    Inker LA; Chaudhari J
    Curr Opin Nephrol Hypertens; 2020 Nov; 29(6):581-590. PubMed ID: 33009129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic Modelling of Chronic Kidney Disease: A Systematic Literature Review to Inform Conceptual Model Design.
    Sugrue DM; Ward T; Rai S; McEwan P; van Haalen HGM
    Pharmacoeconomics; 2019 Dec; 37(12):1451-1468. PubMed ID: 31571136
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) study.
    Inaguma D; Imai E; Takeuchi A; Ohashi Y; Watanabe T; Nitta K; Akizawa T; Matsuo S; Makino H; Hishida A;
    Clin Exp Nephrol; 2017 Jun; 21(3):446-456. PubMed ID: 27412450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Consensus document for the detection and management of chronic kidney disease].
    Martínez-Castelao A; Górriz JL; Bover J; Segura-de la Morena J; Cebollada J; Escalada J; Esmatjes E; Fácila L; Gamarra J; Gràcia S; Hernández-Moreno J; Llisterri-Caro JL; Mazón P; Montañés R; Morales-Olivas F; Muñoz-Torres M; de Pablos-Velasco P; de Santiago A; Sánchez-Celaya M; Suárez C; Tranche S
    Semergen; 2014; 40(8):441-59. PubMed ID: 25282133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease.
    Rodríguez-Ortiz ME; Pontillo C; Rodríguez M; Zürbig P; Mischak H; Ortiz A
    Sci Rep; 2018 Oct; 8(1):15940. PubMed ID: 30374033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic performance of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation at estimating glomerular filtration rate in adults with diabetes mellitus: a systematic review and meta-analysis protocol.
    Zafari N; Churilov L; MacIsaac RJ; Torkamani N; Baxter H; Kiburg KV; Ekinci E
    BMJ Open; 2019 Aug; 9(8):e031558. PubMed ID: 31473625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary Care of the Patient with Chronic Kidney Disease.
    Kiefer MM; Ryan MJ
    Med Clin North Am; 2015 Sep; 99(5):935-52. PubMed ID: 26320040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The kidney and cardiovascular outcome trials.
    Bloomgarden Z
    J Diabetes; 2018 Feb; 10(2):88-89. PubMed ID: 29031006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Practical Approach to Detection and Management of Chronic Kidney Disease for the Primary Care Clinician.
    Vassalotti JA; Centor R; Turner BJ; Greer RC; Choi M; Sequist TD;
    Am J Med; 2016 Feb; 129(2):153-162.e7. PubMed ID: 26391748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The CKD Outcomes and Practice Patterns Study (CKDopps): Rationale and Methods.
    Mariani L; Stengel B; Combe C; Massy ZA; Reichel H; Fliser D; Pecoits-Filho R; Lopes AA; Yamagata K; Wada T; Wong MM; Speyer E; Port FK; Pisoni RL; Robinson BM
    Am J Kidney Dis; 2016 Sep; 68(3):402-13. PubMed ID: 27113505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials.
    Heerspink HJL; Greene T; Tighiouart H; Gansevoort RT; Coresh J; Simon AL; Chan TM; Hou FF; Lewis JB; Locatelli F; Praga M; Schena FP; Levey AS; Inker LA;
    Lancet Diabetes Endocrinol; 2019 Feb; 7(2):128-139. PubMed ID: 30635226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determining the research priorities for patients with chronic kidney disease not on dialysis.
    Hemmelgarn BR; Pannu N; Ahmed SB; Elliott MJ; Tam-Tham H; Lillie E; Straus SE; Donald M; Barnieh L; Chong GC; Hillier DR; Huffman KT; Lei AC; Villanueva BV; Young DM; Fowler EA; Manns BJ; Laupacis A
    Nephrol Dial Transplant; 2017 May; 32(5):847-854. PubMed ID: 27190349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.